35 studies found for:    Arnold-Chiari Malformation
Show Display Options
Rank Status Study
21 Completed Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch
Condition: Healthy
Intervention: Drug: testosterone
22 Completed Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate gel;   Drug: placebo
23 Completed
Has Results
Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems
Condition: Hypogonadism
Intervention: Drug: testosterone matrix transdermal system
24 Active, not recruiting Assessment of Efficacy and Safety of 3 Different Doses of co.Don Chondrosphere to Treat Large Cartilage Defects
Conditions: Large Articular Cartilage Lesions of the Femoral;   Condyle, Trochlea, Tibia or Retropatellar
Intervention: Drug: co.don chondrosphere®
25 Completed A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel
Condition: Actinic Keratoses
Intervention: Drug: PEP005
26 Not yet recruiting Corneal Cross-Linking Comparing Variables
Condition: Unstable Corneas
Interventions: Drug: Epithelium-On Riboflavin;   Drug: Epithelium-Off Riboflavin;   Device: UV Light - Continuous Beam;   Device: UV Pulsed Beam
27 Completed Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005
Condition: Actinic Keratoses
Intervention: Drug: PEP005
28 Terminated
Has Results
Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment
Conditions: Multiple Sclerosis;   Cognitive Impairment
Interventions: Drug: Rivastigmine transdermal patch;   Drug: Placebo
29 Completed Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects
Condition: Parkinson's Disease
Interventions: Drug: Rotigotine;   Other: Placebo
30 Recruiting Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions
Condition: Actinic Keratosis
Intervention: Drug: Ingenol mebutate
31 Completed
Has Results
Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Rotigotine;   Other: Placebo;   Drug: Moxifloxacin infusion;   Other: Placebo infusion
32 Completed
Has Results
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 5 cm^2 transdermal patch;   Drug: Rivastigmine 10 cm^2 transdermal patch
33 Recruiting Efficacy and Safety Study of co.Don Chondrosphere to Treat Cartilage Defects
Condition: Articular Cartilage Lesion of the Femoral Condyle
Interventions: Drug: co.don chondrosphere®;   Procedure: Microfracture
34 Completed Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis
Condition: Actinic Keratosis
Intervention: Drug: Ingenol once daily for two consecutive days
35 Recruiting Prenatal Surgical Repair of Fetal Myelomeningocele
Condition: Foetus With Myelomeningocele
Intervention: Procedure: prenatal surgical repair of fetal myelomeningocele

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years